Assessment of postoperative pain relief in patients coming for laparoscopic abdomen surgeries using two different drugs under ultrasound guidance

Assessment of postoperative analgesic effect of Bupivacaine and Magnesium sulphate vs Bupivacaine and Dexmedetomidine in ultrasound-guided Transversus abdominis plane block for all laparoscopic surgeries - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/064042

Enrollment

Registered

2024-03-12

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: 0.25% Inj Bupivacaine and 0.5 mcg/kg Dexmedetomidine Group B: Prospectively for the one year duration Patients posted for Laparoscopic abdominal surgery will be randomly taken as Group

Eligibility

Inclusion criteria

Inclusion criteria: Patients posted all laparoscopic surgeries ASA grade 1 and ASA grade 2 patient who are willing to participate

Exclusion criteria

Exclusion criteria: ASA grade 3 and ASA grade 4 Patients who are known case of hypersensitivity to amide group of local anesthetic agents Patients with coagulation disorders patient who are not willing to participate

Design outcomes

Primary

Measure	Time frame
To observe the duration of analgesia between the two different study groupsTimepoint: by observing hourly VAS score	—

Secondary

Measure	Time frame
To find out the time of first rescue analgesiaTimepoint: To find out the Pain score at 4hr 8hr 12hr 18hr and 24hr postoperatively	—

Countries

India

Contacts

Public ContactKala Balasubramanian

Sree Balaji medical college and hospital Chennai

kalamhn@gmail.com9444680908

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026